UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000062379
Receipt number R000071321
Scientific Title Effects of Visual, Auditory, and Physical Stimuli from an Intimate Male Partner on Pain Sensitivity in Adults
Date of disclosure of the study information 2026/09/01
Last modified on 2026/07/29 10:46:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of Visual, Auditory, and Physical Stimuli from an Intimate Male Partner on Pain Sensitivity in Adults

Acronym

Effects of Visual, Auditory, and Physical Stimuli from an Intimate Male Partner on Pain Sensitivity in Adults

Scientific Title

Effects of Visual, Auditory, and Physical Stimuli from an Intimate Male Partner on Pain Sensitivity in Adults

Scientific Title:Acronym

Effects of Visual, Auditory, and Physical Stimuli from an Intimate Male Partner on Pain Sensitivity in Adults

Region

Japan


Condition

Condition

Not applicable

Classification by specialty

Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to investigate the effects of visual and auditory stimuli, as well as physical contact, from an intimate male partner on pain sensitivity in young female adults.

Basic objectives2

Others

Basic objectives -Others

This study examines within-participant differences in pain sensitivity depending on whether their partners are present or absent.

Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Pain intensity with the visual analogue scale

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

partners are present.

Interventions/Control_2

Partners are absent.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

29 years-old >=

Gender

Female

Key inclusion criteria

1. Individuals who have fully understood the study procedures and provided both oral and written informed consent.
2. Healthy Japanese adult women aged 18 to 29 years (inclusive) at the time of participation.
3. Individuals with no current pain (acute or chronic) at the time of the study.
4. Non-smokers.
5. Individuals who have obtained sufficient sleep prior to participation.
6. Individuals who have not engaged in exercise exceeding 4 hours per day, both on the day before and on the day of the experiment.
7. Individuals with no history or current diagnosis of autonomic nervous system disorders, cardiovascular disorders, central or peripheral nervous system disorders, or conditions involving sensory or dermatological abnormalities.
8. Individuals who have not undergone any form of pharmacological treatment (e.g., oral, transdermal, or injectable administration), including analgesics or centrally acting drugs, within the 3 days prior to the start of the study.
9. Individuals who are within 1 week following the end of menstruation.
10. Individuals who have been in a romantic relationship with their partner for 3 months or longer at the time of application.

Key exclusion criteria

1. Individuals in whom clearly abnormal findings are observed immediately before or during the course of the study.
2. Individuals judged by the principal investigator to be unable to maintain psychological stability, or to be at risk of such instability.
3. Individuals with trauma, skin abnormalities, or other physical abnormalities at the time of the study.
4. Individuals who are taking any analgesics or drugs acting on the central nervous system.
5. Individuals otherwise judged by the investigator to be unable to complete the study, or to be at risk of being unable to do so.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Takahiro
Middle name
Last name Kakeda

Organization

Kawasaki City College of Nursing

Division name

Faculty of Nursing

Zip code

212-0054

Address

4-30-1 Ogura, Saiwai-ward, Kawasaki, Kanagawa, Japan

TEL

+81-44-587-3520

Email

kakeda-t@kawasaki-cn.ac.jp


Public contact

Name of contact person

1st name Takahiro
Middle name
Last name Kakeda

Organization

Kawasaki City College of Nursing

Division name

Faculty of Nursing

Zip code

212-0054

Address

4-30-1 Ogura, Saiwai-ward, Kawasaki, Kanagawa, Japan

TEL

+81-44-587-3520

Homepage URL


Email

kakeda-t@kawasaki-cn.ac.jp


Sponsor or person

Institute

Kawasaki City College of Nursing

Institute

Department

Personal name

Nozomi Matsumura


Funding Source

Organization

JSPS KAKENHI

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethics Committee in Kawasaki City College of Nursing

Address

4-30-1 Ogura, Saiwai-ward, Kawasaki, Kanagawa, Japan

Tel

+81-44-587-3500

Email

ethics@kawasaki-cn.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 06 Month 17 Day

Date of IRB


Anticipated trial start date

2026 Year 08 Month 15 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 07 Month 29 Day

Last modified on

2026 Year 07 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071321